Internal Medicine Clinic II, Helios Vogtland Klinikum Plauen, Academic Teaching Hospital of Leipzig University, Leipzig, Germany.
EuroIntervention. 2016 Feb;11(11):e1231-6. doi: 10.4244/EIJV11I11A244.
A systematic description of the percutaneous treatment of chronic total occlusions (CTOs) of the right coronary artery (RCA) using ipsilateral collateral connections (CCs) for the retrograde approach has never been carried out. Our aim was to investigate this issue systematically.
Based on the experiences of a European high-volume CTO centre: 1) a generalised scheme of the varying anatomic courses of ipsilateral CCs bridging CTOs of the RCA was developed; 2) important stepwise technical advice for the ipsilateral retrograde approach was formulated; and 3) a supportive clinical case series was assessed. Of a total of 158 patients with CTOs of the RCA, 30% (n=47) revealed ipsilateral CCs of the RCA. Five different types (A-E) of ipsilateral CCs were assessed. The retrograde ipsilateral approach was attempted in nine patients, and was completed successfully in 89% (8/9 patients). Median left ventricular ejection fraction was 56% (interquartile range [IQR]: 50-60%) and mean J-CTO score was 2.9 (standard error of mean [SEM]: ±0.3). Median procedural duration time was 150 min (IQR 117-160 min), with a median applied amount of contrast of 360 ml (IQR 270-400 ml). No relevant complications, such as acute renal failure or severe bleedings, occurred.
The percutaneous treatment of CTOs of the RCA using ipsilateral CCs for the retrograde approach might provide a novel treatment alternative for patients with CTOs of the RCA in specific clinical situations.
使用同侧侧支循环(CCs)进行逆行入路治疗右冠状动脉(RCA)慢性完全闭塞(CTO)的经皮治疗方法尚未得到系统描述。我们的目的是系统地研究这个问题。
基于一个欧洲大容量 CTO 中心的经验:1)制定了一种用于 RCA CTO 的同侧 CC 桥接的不同解剖学路径的通用方案;2)提出了同侧逆行入路的重要分步技术建议;3)评估了一个支持性的临床病例系列。在总共 158 例 RCA CTO 患者中,30%(n=47)显示 RCA 的同侧 CC。评估了五种不同类型(A-E)的同侧 CC。有 9 名患者尝试了逆行同侧入路,其中 89%(8/9 名患者)成功完成。中位左心室射血分数为 56%(四分位距 [IQR]:50-60%),平均 J-CTO 评分 2.9(标准误差均值 [SEM]:±0.3)。中位手术时间为 150 分钟(IQR 117-160 分钟),中位使用造影剂量为 360 毫升(IQR 270-400 毫升)。无急性肾衰竭或严重出血等相关并发症发生。
在特定临床情况下,使用同侧 CC 进行逆行入路治疗 RCA CTO 可能为 RCA CTO 患者提供一种新的治疗选择。